Very few screening tests have been reported to reduce mortality in asymptomatic individuals.1 Nevertheless, there is an enduring belief in the benefit of using diagnostic tests to find disease in its earliest stages. Hospitals have responded to the demand for early diagnosis by establishing executive screening programs targeted to wealthy individuals who are able to pay directly for screening tests that are generally not covered by insurance.2 Since cardiovascular disease represents the leading cause of mortality in the United States,3 we assessed the cardiovascular examinations included in the executive health screening programs offered by the top hospitals for cardiology and heart surgery as ranked by US News & World Report.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Ge A, Brown DL. Assessment of Cardiovascular Diagnostic Tests and Procedures Offered in Executive Screening Programs at Top-Ranked Cardiology Hospitals. JAMA Intern Med. Published online January 13, 2020. doi:10.1001/jamainternmed.2019.6607
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: